SCHEMBL4205408

SCHEMBL4205408

CC(C)(C)Oc1ccc(-n2nnnc2C(F)(F)F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.45
ALDH1A1 P00352 4/20 0.45
HTT P42858 3/20 0.45
HPGD P15428 2/20 0.45
CACNA1B Q00975 2/20 0.45
APBA1 Q02410 2/20 0.45
HSP90AA1 P07900 1/20 0.45
PRMT1 Q99873 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CCR6 P51684 1/20 0.41
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NOTUM Q6P988 1/20 0.37
KDM4E B2RXH2 1/20 0.36
LMNA P02545 2/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4212269 0.88 ALDH1A1 (0.43) MAPTALDH1A1HTTHPGDCACNA1B
SCHEMBL4216728 0.84 SMN1; SMN2 (0.55) MAPTALDH1A1HTTHPGDCACNA1B
SCHEMBL4210628 0.84 ALDH1A1 (0.43) MAPTALDH1A1HTTHPGDCACNA1B
SCHEMBL4202175 0.81 PRMT1 (0.49) MAPTALDH1A1HTTHPGDCACNA1B
SCHEMBL4215358 0.81 MAPT (0.52) MAPTALDH1A1HTTHPGDCACNA1B
SCHEMBL4202368 0.80 LMNA (0.48) MAPTALDH1A1HTTHPGDCACNA1B
SCHEMBL5551503 0.79 ALDH1A1 (0.70) MAPTALDH1A1HTTHPGDCACNA1B
SCHEMBL4199024 0.78 CYP19A1 (0.46) MAPTALDH1A1HTTHPGDCACNA1B
SCHEMBL4205395 0.78 ALDH1A1 (0.49) MAPTALDH1A1HTTHPGDCACNA1B
SCHEMBL4205411 0.77 PRMT1 (0.42) MAPTALDH1A1HTTHPGDCACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579480-B2 Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same TOYO KASEI KOGYO COMPANY LIMITED (JP) 2009-08-25 US disclosed
US-20070060630-A1 Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same TOYO KASEI KOGYO COMPANY LIMITED (JP) 2007-03-15 US disclosed
EP-1650198-A1 ALKOXYTETRAZOL-1-YLBENZALDEHYDE COMPOUND AND PROCESS FOR PRODUCING THE SAME Toyo Kasei Kogyo Company Limited (JP) 2006-04-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060630-A1 Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same ALDH7A1, NAT1, ARSA MAPT 3279/4885ALDH1A1 4/4885HTT 494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.